abstract |
The present invention relates to substituted dihydroimidazolones, particularly [1- (4-chlorophenyl) -4- (4-morpholinyl) -2,5-dihydro-1H-imidazole-, for treating epilepsy in dogs. 2-on] (AWD 131-138) or a physiologically acceptable salt thereof. |